Occidental Asset Management’s AIM ImmunoTech AIM Stock Holding History

Occidental Asset Management’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4	Closed	-$3K	–	152
2019 Q1	$3K	Hold	4	–	–	﹤0.01%	144
2018 Q4	$3K	Hold	4	–	–	﹤0.01%	137
2018 Q3	$4K	Hold	4	–	–	﹤0.01%	156
2018 Q2	$5K	Hold	4	–	–	﹤0.01%	149
2018 Q1	$6K	Hold	4	–	–	﹤0.01%	143
2017 Q4	$5K	Hold	4	–	–	﹤0.01%	145
2017 Q3	$5K	Hold	4	–	–	﹤0.01%	136
2017 Q2	$8K	Hold	4	–	–	﹤0.01%	137
2017 Q1	$9K	Hold	4	–	–	0.01%	126
2016 Q4	$11K	Hold	4	–	–	0.01%	129
2016 Q3	$20K	Hold	4	–	–	0.02%	93
2016 Q2	$22K	Hold	4	–	–	0.02%	95
2016 Q1	$25K	Hold	4	–	–	0.03%	75
2015 Q4	$184K	Hold	4	–	–	0.24%	64
2015 Q3	$390K	Hold	4	–	–	0.55%	41
2015 Q2	$466K	Hold	4	–	–	0.62%	40
2015 Q1	$521K	Hold	4	–	–	0.65%	36
2014 Q4	$570K	Hold	4	–	–	0.87%	31
2014 Q3	$732K	Hold	4	–	–	1.19%	21
2014 Q2	$707K	Hold	4	–	–	1.21%	20
2014 Q1	$912K	Buy	+4	New	+$84.6K	1.63%	15

Other funds holding AIM

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Occidental Asset Management's AIM Position: Q2 2019 in Review

Occidental Asset Management sold out of AIM ImmunoTech (AIM) in Q2 2019, closing a stake of 4 shares — an estimated $3K sold.

Occidental Asset Management first reported a position in AIM in Q1 2014 and held it in 21 quarters. The position peaked at $912K in Q1 2014. 7 funds tracked by Wall St. Rank hold AIM as of Q2 2019.

Occidental Asset Management reported no remaining AIM ImmunoTech position as of Q2 2019 after selling out during the quarter.
Occidental Asset Management sold 4 AIM ImmunoTech shares in Q2 2019, an estimated $3K.
Occidental Asset Management first reported a position in AIM ImmunoTech in Q1 2014 and held it in 21 quarters.
Occidental Asset Management's AIM ImmunoTech position peaked at $912K in Q1 2014.
7 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2019.

Based on Occidental Asset Management's 13F filing for Q2 2019, filed 2 Aug 2019.